跳至主要内容
临床试验/ChiCTR2500110461
ChiCTR2500110461已完成Unknown

Effect of Topical NSAIDs (Diclofenac 0.1%, Nepafenac 0.1%, Nepafenac 0.3%) on Pain Management During Intravitreal Injections: A Prospective, Non-Randomized, Case-Control Trial

Self-funded1 个研究点 分布在 1 个国家开始时间: 2025年10月17日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
Self-funded
试验地点
1
主要终点
Mean patient-reported pain score

研究概览

简要总结

Primary objective of the study is to measure the effect of the addition of pre-operative topical NSAID on perceived pain during intravitreal injection procedures

研究设计

研究类型
Interventional
主要目的
非随机对照试验

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • Age 18 years or older;
  • Scheduled to receive a monocular intravitreal injection of an anti-VEGF agent;
  • Able to understand, consent, and use the Visual Analog Scale for pain reporting.

排除标准

  • Known hypersensitivity or allergy to proparacaine, diclofenac, nepafenac, or any other NSAID;
  • Presence of active or severe ocular surface disease (e.g., keratitis, severe dry eye);
  • History of ocular surgery within the past 3 months;
  • Concurrent use of any systemic or topical NSAIDs for any other medical reason;
  • A diagnosed anxiety disorder, severe needle phobia, or inability to comprehend the study protocol.

研究组 & 干预措施

Group 1

Group 2

Group 3

Group 4

结局指标

主要结局

Mean patient-reported pain score

时间窗: Measured once, immediately following the completion of the intravitreal injection procedure

次要结局

未报告次要终点

研究者

发起方
Self-funded

研究点 (1)

Loading locations...

相似试验